The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling
Background A goal of cancer vaccines is to induce strong T cell responses to tumor antigens, but the delivery method, schedule, and formulation of cancer vaccines have not yet been optimized. Adjuvants serve to increase the immune response against vaccine antigens. However, little is known about the...
Main Authors: | Craig L Slingluff, Pankaj Kumar, Max O Meneveau, Kevin T Lynch, Sapna P Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-03-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/3/e003533.full |
Similar Items
-
Licensed liposomal vaccines and adjuvants
in the antigen delivery system
by: Yuriy Krasnopolsky, et al.
Published: (2022-12-01) -
Intratumoral IFN-γ or topical TLR7 agonist promotes infiltration of melanoma metastases by T lymphocytes expanded in the blood after cancer vaccine
by: Walter C Olson, et al.
Published: (2023-02-01) -
Characterising novel vaccine adjuvants in eliciting antigen-specific CD8+ T cell immunity
by: He, A
Published: (2023) -
Polymer Chemistry Defines Adjuvant Properties and Determines the Immune Response against the Antigen or Vaccine
by: Akhilesh Kumar Shakya, et al.
Published: (2023-08-01) -
Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells
by: Srinivasa Reddy Bonam, et al.
Published: (2023-01-01)